Evidence map›Paper›PMID 42524520›Full record

ArticleInternational journal of biological sciences2026

Targeting Kupffer Cell CD44-Mediated Ammonia Death via the ELAVL1-GLS Metabolic Circuit in Radiation-Induced Liver Disease.

Yanyan Lin, Shuxuan Wang, Bufu Tang, Pan Zhou, Xiaojun Zhang, Huanliang Chen, Jiaoyang Yang, Shisuo Du, Qian-Qian Zhao, Zhao-Chong Zeng

Abstract read
In one paragraph

Article in International journal of biological sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yanyan LinDepartment of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Shuxuan WangDepartment of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Bufu TangDepartment of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Pan ZhouDepartment of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Xiaojun ZhangDepartment of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Huanliang ChenDepartment of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Jiaoyang YangDepartment of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Shisuo DuDepartment of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Qian-Qian ZhaoDepartment of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Zhao-Chong ZengDepartment of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Radiation-induced liver disease (RILD) remains a major dose-limiting toxicity in liver cancer radiotherapy. However, the underlying mechanisms, particularly the immunometabolic reprogramming that sustains inflammatory amplification following irradiation, are still poorly understood. Here, we report that Kupffer cell (KC) depletion significantly attenuated radiation-induced liver inflammation and injury. Irradiation markedly upregulated CD44 expression in KCs, and single-cell RNA sequencing revealed a CD44⁺ macrophage subset associated with injury, inflammatory activation, and metabolic stress signatures. Consistently, genetic deletion or pharmacological inhibition of CD44 protected against RILD by suppressing KC M1 polarization, oxidative stress accumulation, and inflammatory cytokine output. Furthermore, radiation exposure profoundly disrupted nitrogen homeostasis and increased intracellular ammonia levels, effects that were abrogated by CD44 deficiency. Mechanistically, CD44 stabilized the RNA-binding protein ELAVL1 by inhibiting its proteasomal degradation, which subsequently increased the abundance and activity of glutaminase (GLS), elevated the intracellular ammonia burden, and triggered macrophage death. Pharmacological inhibition of GLS with CB-839 rescued the injurious phenotype, while exogenous NH

Indexed as

AmmoniaELAV-Like Protein 1Hyaluronan ReceptorsKupffer CellsLiver DiseasesAnimalsMiceMice, Inbred C57BLAmmoniaElavl1 protein, mouseELAV-Like Protein 1Hyaluronan Receptorsammonia-induced cell deathCD44glutaminaseKupffer cellsradiation-induced liver disease

Identifiers

PMID42524520
PMCPMC13412084

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.